BACKGROUND: The authors conducted a randomized clinical trial to evaluate the efficacy of a biopsychosocial intervention for patients who were at high risk (HR) of progressing from acute to chronic temporomandibular disorder (TMD)-related pain. METHODS: The authors classified subjects' risk using a predictive algorithm and randomized them into an early-intervention (EI) or a nonintervention (NI) group. The EI included cognitive behavioral skills training and biofeedback. The authors assessed pain and psychosocial measures at intake and at a one-year follow-up. Subjects' self-reported pain levels were measured on an analog scale and as a response to palpation. RESULTS: At one year, EI-group subjects had significantly lower levels of self-reported pain and depression. At one year, more NI-group subjects than EI-group subjects had utilized health care for jaw-related pain. NI-group subjects were 12.5 times as likely to have a somatoform disorder, more than seven times as likely to have an anxiety disorder, and 2.7 times more likely to have an affective disorder at one year, compared with EI-group subjects. CONCLUSIONS: EI-group subjects had reduced pain levels, improved coping abilities and reduced emotional distress at one year. CLINICAL IMPLICATIONS: The TMD-related pain experience is complex and requires early identification with a biopsychosocial EI to achieve maximal, sustainable results.
RCT Entities:
BACKGROUND: The authors conducted a randomized clinical trial to evaluate the efficacy of a biopsychosocial intervention for patients who were at high risk (HR) of progressing from acute to chronic temporomandibular disorder (TMD)-related pain. METHODS: The authors classified subjects' risk using a predictive algorithm and randomized them into an early-intervention (EI) or a nonintervention (NI) group. The EI included cognitive behavioral skills training and biofeedback. The authors assessed pain and psychosocial measures at intake and at a one-year follow-up. Subjects' self-reported pain levels were measured on an analog scale and as a response to palpation. RESULTS: At one year, EI-group subjects had significantly lower levels of self-reported pain and depression. At one year, more NI-group subjects than EI-group subjects had utilized health care for jaw-related pain. NI-group subjects were 12.5 times as likely to have a somatoform disorder, more than seven times as likely to have an anxiety disorder, and 2.7 times more likely to have an affective disorder at one year, compared with EI-group subjects. CONCLUSIONS: EI-group subjects had reduced pain levels, improved coping abilities and reduced emotional distress at one year. CLINICAL IMPLICATIONS: The TMD-related pain experience is complex and requires early identification with a biopsychosocial EI to achieve maximal, sustainable results.
Authors: Silviana Braz de Oliveira; Silvia Regina Dowgan Tesseroli de Siqueira; Ana Rosa Sanvovski; Lúcia Maria Thompson Barros do Amaral; José Tadeu Tesseroli de Siqueira Journal: J Clin Psychol Med Settings Date: 2008-12-10
Authors: C C Peck; J-P Goulet; F Lobbezoo; E L Schiffman; P Alstergren; G C Anderson; R de Leeuw; R Jensen; A Michelotti; R Ohrbach; A Petersson; T List Journal: J Oral Rehabil Date: 2014-01 Impact factor: 3.837
Authors: Cheryl Ritenbaugh; Richard Hammerschlag; Samuel F Dworkin; Mikel G Aickin; Scott D Mist; Charles R Elder; Richard E Harris Journal: J Pain Date: 2012-10-09 Impact factor: 5.820
Authors: Gary C Anderson; Yoly M Gonzalez; Richard Ohrbach; Edmond L Truelove; Earl Sommers; John O Look; Eric L Schiffman Journal: J Orofac Pain Date: 2010
Authors: M Bérubé; C Gélinas; N Feeley; G Martorella; J Côté; G Y Laflamme; D M Rouleau; M Choinière Journal: Pain Med Date: 2019-10-01 Impact factor: 3.750